A Phase II randomised study investigating the efficacy of standard Or high-dose Ofatumumab in combination with chemotherapy in relapsed chronic lymphocytic leukaemia.
Authors
Allsup, DHoward, D
Munir, T
Hockaday, A
Rawstron, A
Collett, L
McParland, L
Oughton, J
Bloor, Adrian
Phillips, D
Nathwani, A
Shankara, P
Turner, D
Hillmen, P
Affiliation
Hull & East Yorkshire NHS Trust, Haematol, Kingston Upon Hull, N HumbersideIssue Date
2017